We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
National Grid
NGG
$81.3B
| $8.69M | 0.04% |
153,742
+129,783
| +542% | +$7.38M |
|
402
AeroVironment
AVAV
$9.45B
| $8.65M | 0.04% |
86,388
| – | – |
|
403
Labcorp
LH
$25.9B
| $8.63M | 0.04% |
36,424
+30,145
| +480% | +$6.87M |
|
404
POSCO
PKX
$17.5B
| $8.55M | 0.04% |
111,377
+39,718
| +55% | +$3.14M |
|
405
Cartesian Therapeutics
RNAC
$268M
| $8.54M | 0.04% |
68,125
-28,482
| -29% | -$3.39M |
|
406
M&T Bank
MTB
$36.2B
| $8.52M | 0.04% |
58,615
-13,529
| -19% | -$2.11M |
|
407
Allogene Therapeutics
ALLO
$694M
| $8.48M | 0.04% |
+325,040
| New | +$9.27M |
|
408
PACCAR
PCAR
$70.1B
| $8.47M | 0.04% |
142,359
+47,808
| +51% | +$2.93M |
|
409
Lamb Weston
LW
$7.19B
| $8.35M | 0.03% |
103,486
-35,443
| -26% | -$2.84M |
|
|
RNAM
410
DELISTED
Avidity Biosciences
RNAM
| $8.31M | 0.03% |
+336,455
| New | +$7.83M |
|
411
Mercury Systems
MRCY
$6.52B
| $8.3M | 0.03% |
125,249
-117,820
| -48% | -$8.14M |
|
412
Nike
NKE
$61.9B
| $8.26M | 0.03% |
53,496
-20,581
| -28% | -$2.77M |
|
413
Entegris
ENTG
$23.2B
| $8.17M | 0.03% |
+66,445
| New | +$7.63M |
|
414
UBS Group
UBS
$176B
| $8.13M | 0.03% |
+530,089
| New | +$8.37M |
|
415
TaskUs
TASK
$669M
| $8.13M | 0.03% |
+237,483
| New | +$7.5M |
|
416
American International
AIG
$41.3B
| $8.05M | 0.03% |
+169,196
| New | +$8.37M |
|
417
Alaska Air
ALK
$5.58B
| $8.02M | 0.03% |
+132,928
| New | +$8.97M |
|
418
Valero Energy
VLO
$85.9B
| $8M | 0.03% |
102,428
-36,709
| -26% | -$2.84M |
|
|
KCAC
419
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
| $7.96M | 0.03% |
+800,000
| New | +$8.03M |
|
|
PRPB
420
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $7.91M | 0.03% |
800,000
| – | – |
|
421
Bank of Montreal
BMO
$127B
| $7.82M | 0.03% |
76,250
-195,230
| -72% | -$19.3M |
|
|
EPIX
422
DELISTED
ESSA Pharma
EPIX
| $7.81M | 0.03% |
273,413
+91,386
| +50% | +$2.66M |
|
423
Consolidated Edison
ED
$39.9B
| $7.79M | 0.03% |
108,593
+68,233
| +169% | +$5.24M |
|
|
CERN
424
DELISTED
Cerner Corp
CERN
| $7.77M | 0.03% |
99,359
-13,664
| -12% | -$1.05M |
|
425
MPLX
MPLX
$59.7B
| $7.75M | 0.03% |
261,869
-425,690
| -62% | -$12M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.